Esperion Therapeutics, Inc. — Form D/A
Esperion Therapeutics, Inc. of Ann Arbor, MI, a company, filed a Form D amendment with the SEC on 2010-02-12. The offering totals $38.3M, of which $27.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2010-02-12
- Form: D/A
- Accession: 0001434868-10-000005
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $38.3M
- Amount sold: $27.8M
- Remaining: $10.5M
- Investors: 7
- Date of first sale: 2008-04-28
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-118048
Issuer
- Name: Esperion Therapeutics, Inc.
- CIK: 0001434868
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 3891 Ranchero Drive, Suite 150, Ann Arbor, MI, 48108
- Phone: 734-887-3903
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Alison S de Bord | Director | San Francisco, CA |
| Patrick G Enright | Director | San Diego, CA |
| Tim M Mayleben | Director | Radnor, PA |
| Tim M Mayleben | Executive Officer | Radnor, PA |
| Louis G Lange | Director | San Francisco, CA |
| Gilbert S Omenn | Director | Norcross, GA |
| Antonio M Gotto, Jr. | Director | Ann Arbor, MI |
| Daniel M Janney | Director | Ann Arbor, MI |
| Nicole S Vitullo | Director | Ann Arbor, MI |
| Roger S Newton | Director | Ann Arbor, MI |
| Roger S Newton | Executive Officer | Ann Arbor, MI |
| Patrick S Enright | Director | Ann Arbor, MI |
| Mark E McGovern | Director | Ann Arbor, MI |
| Timothy M Mayleben | Director | Ann Arbor, MI |
| Noah L Rosenberg | Executive Officer | Plymouth, MI |
| Daniel A Janney | Director | Plymouth, MI |
| Troy A Ignelzi | Executive Officer | Plymouth, MI |
| Nicole G Vitullo | Director | Plymouth, MI |
| Dov A Goldstein | Director | NEW YORK, NY |
| Louis M Lange | Director | Palo Alto, CA |
| Alison S Kiley | Director | San Francisco, CA |
| Dov S Goldstein | Director | New York, NY |
Other filings by this issuer (3)
More